go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Pfizer Healthcare Ireland
9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Patient Information Leaflet last updated on medicines.ie: 27/01/2012
PIL SUTENT 12.5mg, 25mg, 37.5mg and 50mg Hard Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 27/01/2012 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/01/2012 and displayed until 27/01/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to further information section
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 25/08/2011 and displayed until 13/01/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to MA holder contact details
Updated on 12/01/2011 and displayed until 25/08/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Change to MA holder contact details
Updated on 07/12/2010 and displayed until 12/01/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 03/12/2010 and displayed until 07/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 13/08/2010 and displayed until 03/12/2010
Reasons for adding or updating:
  • Change to further information section
Updated on 27/04/2010 and displayed until 13/08/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to further information section
Updated on 15/09/2009 and displayed until 27/04/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 07/09/2009 and displayed until 15/09/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to further information section
Updated on 15/06/2009 and displayed until 07/09/2009
Reasons for adding or updating:
  • Change to further information section
  • Introduction of new strength
  • Improved electronic presentation
Updated on 20/02/2009 and displayed until 15/06/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to further information section
Updated on 03/09/2008 and displayed until 20/02/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/02/2008 and displayed until 03/09/2008
Reasons for adding or updating:
  • Addition of marketing authorisation holder
  • Change due to harmonisation of patient information leaflet
  • Change to warnings or special precautions for use
Updated on 13/02/2007 and displayed until 05/02/2008
Reasons for adding or updating:
  • Change to date of revision
  • Addition of joint PIL covering all presentations
  • Addition of marketing authorisation holder
Updated on 02/08/2006 and displayed until 13/02/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Sunitinib malate